Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocular Therapeutix

6.93
-0.0700-1.00%
Post-market: 6.930.00000.00%16:33 EDT
Volume:1.85M
Turnover:12.68M
Market Cap:1.10B
PE:-6.03
High:7.10
Open:7.00
Low:6.69
Close:7.00
Loading ...
Jun 21, 2019

Major Issues Report

Current report, item 8.01
Jun 17, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 17, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 14, 2019

Major Issues Report

Current report, item 5.07
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 10, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 06, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 06, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 03, 2019

Major Issues Report

Current report, item 8.01
May 31, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
May 30, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
May 20, 2019

Major Issues Report

Current report, item 8.01
May 15, 2019

Major Issues Report

Current report, item 5.02
May 10, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]